The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: A preliminary report.
E. Efstathiou
Research Funding - Medivation
M. A. Titus
No relevant relationships to disclose
D. Tsavachidou
No relevant relationships to disclose
A. Hoang
No relevant relationships to disclose
M. Karlou
No relevant relationships to disclose
S. Wen
No relevant relationships to disclose
P. Troncoso
No relevant relationships to disclose
R. Ashe
No relevant relationships to disclose
C. J. Berman
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
J. Mohler
No relevant relationships to disclose
C. Logothetis
Consultant or Advisory Role - Medivation
Research Funding - Medivation